期刊文献+

次抑菌浓度的喹诺酮类药物诱导人型支原体耐药与交叉耐药的研究 被引量:1

The Study of Inducing Mycoplasma Hominis Resistance and Cross-resistance With Antibiotic Subinhibitory Concentration of Quinoloes.
暂未订购
导出
摘要 [目的 ] 了解Mh对喹喏酮类药物的耐药状况 ,指导合理使用抗生素。 [方法 ] 将标准株与敏感株分别进行诱导耐药与交叉耐药试验。 [结果 ] 氧氟沙星、左旋氧氟沙星、盐酸环丙沙星诱导的Mh对氧氟沙星、左旋氧氟沙星、盐酸环丙沙星、司帕沙星均产生耐药。司帕沙星诱导耐药的Mh对氧氟沙星、盐酸环丙沙星、左旋氧氟沙星无明显交叉耐药。 [结论 ] Mh长期接触低浓度喹诺酮类药物会诱导产生耐药性 ,而且大多数呈现稳定耐药与交叉耐药。 Objective] To acquire the information about the present resistance characteristics in Mycoplasma hominis(Mh), especially in Quinolones, and to instruct reasonable application of antibiotics clinically. [Methods] A total of 5 isolates Mh from clinical specimens and 1 standard strain were induced resistance and cross-resistance. [Results] OFX-resistant Mh showed cross-resistance to LFX and CFX and SFX. Similarly, LFX-resistance Mh cross-resistance to OFX and CFX and SFX, CFX-resistance Mh cross-resistance to OFX and LFX and SFX. However, SFX-resistance Mh did not appear cross-resistance to OFX and LFX and CFX. [Conclution] The strains of Mh can produce resistant and corss-resistant characteristics when they long time contact with antibiotic subinhibitory concentraction of Quinolones.
出处 《实用预防医学》 CAS 2000年第1期12-14,共3页 Practical Preventive Medicine
基金 湖南省科委资助
关键词 人型支原体 喹诺酮类药物 交叉耐药 Mycoplasma hominis(Mh), Cross-Resistance, Quinolones.
  • 相关文献

参考文献6

  • 1CECILE M BEBEAR, HELENE RENAUDIN. ALAIN CHARRON. et al. Altrations in Topoisomerase IV and DNA Gyrase in Quinolone - Resistant Mutants of Mycoplasma hominis Obtained In Vitro. Antimicrobial Agents and chemotherapy. Sept. 1998.p. 2304~2311.
  • 2吴移谋,宋颖.泌尿生殖道支原体感染的实验室诊断研究[J].中华医学检验杂志,1991,14(3):157-159. 被引量:33
  • 3吴移谋,尹卫国,余敏君,刘腾飞,占利生.3种抗菌药物体外抗5种支原体的活性研究[J].中国现代医学杂志,1996,6(1):8-9. 被引量:14
  • 4Michea-Hamzehpour M. Kahr A. Pechere J C. In vitro stepwise selection of resistance to quinolones. β-lactams and amikacin in nosocomial Gram- negative bacilli. Infection.1994. (suppl 2):105.
  • 5任冰,陈民钧.金葡球菌对喹诺酮类的耐药机制[J].国外医药(抗生素分册),1997,18(5):386-389. 被引量:32
  • 6Bebear C M. Charron A. Bove J M. et al. Coloning and Nucleotide Sequences of the Topisomerase IV par C and par E Genes of Mycoplasma hominis. Antimicrobial Agents and chemotherapy. Sept. 1998.42:2024~2031.

共引文献73

同被引文献7

  • 1叶萍,王晓川,吴志华.人型支原体氟喹诺酮耐药性的分子机制[J].中国麻风皮肤病杂志,2005,21(10):805-807. 被引量:10
  • 2Michea-Hamzehpour M,Kahr A,Pechere JC.In vitro stepwise selection of resistance to quinolones,β-lsctams and amikacin in nosocomial Gramnegative bacilli[J].Infection,1994,2:105.
  • 3Bebear CM,Bove JM,Bebear C,et al.Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones[J].Antimicrob Agents Chemother,1997,41 (2):269 ~ 273.
  • 4Bebear CM,Renaudin H,Charron A,et al.Alterations in topoisomerase Ⅳ and DNA gyrase in quinolone-resistant mutants of mycoplasma hominis obtained in vitro[J].Antimicrob Agents Chemother,1998,42 (9):2304 ~2311.
  • 5Gruson D,Pereyre S,Renaudin H,et al.In vitro development of resistance to six and four fluoroquinolones in mycoplasma pneumoniae and mycoplasma hominis,respectively[J].Antimicrob Agents Chemother,2005,49(3):1190~ 1193.
  • 6Pereyre S,Renaudin H,Bebear C,et al.In vitro activities of the newer quinolones garenoxacin,gatifloxacin,and gemifloxacin against human mycoplasmas[J].Antimicrob Agents Chemother,2004,48:3165 ~ 3168.
  • 7吴移谋,余敏君,尹卫国,朱翠明,刘腾飞,曾铁兵,谭立志.从临床标本中定量检测泌尿生殖道支原体耐药性的研究[J].中华医学检验杂志,1998,21(6):335-337. 被引量:99

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部